Moderna (MRNA) reported Q3 2026 results on 6 Nov 2026. Earnings per share came in at $0.38, against an analyst average of -$1.35, a surprise of +128.1%.
The quarter ended on 30 Sep 2026.
The company is valued at about $96.4B.
Figures from Yahoo Finance at the time of writing. Not investment advice.